UBS Group’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.18M Buy
126,062
+20,603
+20% +$185K ﹤0.01% 5421
2025
Q4
$854K Sell
105,459
-9,438
-8% -$103K ﹤0.01% 5709
2025
Q3
$1.63M Sell
114,897
-72,135
-39% -$953K ﹤0.01% 5150
2025
Q2
$2.44M Sell
187,032
-119,533
-39% -$1.64M ﹤0.01% 4609
2025
Q1
$4.56M Buy
306,565
+175,874
+135% +$3.02M ﹤0.01% 3877
2024
Q4
$2.37M Sell
130,691
-311,110
-70% -$4.19M ﹤0.01% 4568
2024
Q3
$5.94M Buy
441,801
+76,889
+21% +$1.13M ﹤0.01% 2896
2024
Q2
$5.05M Buy
364,912
+337,214
+1,217% +$5.34M ﹤0.01% 2870
2024
Q1
$519K Sell
27,698
-16,747
-38% -$335K ﹤0.01% 5183
2023
Q4
$1.01M Buy
44,445
+26,529
+148% +$575K ﹤0.01% 4498
2023
Q3
$444K Sell
17,916
-17,302
-49% -$435K ﹤0.01% 4746
2023
Q2
$989K Buy
35,218
+2,857
+9% +$70.9K ﹤0.01% 4251
2023
Q1
$722K Sell
32,361
-25,497
-44% -$668K ﹤0.01% 4391
2022
Q4
$1.54M Buy
57,858
+42,755
+283% +$1.4M ﹤0.01% 3646
2022
Q3
$429K Buy
+15,103
New +$388K ﹤0.01% 4473
2022
Q2
Sell
-17,874
Closed -$387K 10358
2022
Q1
$387K Sell
17,874
-4,542
-20% -$98.5K ﹤0.01% 4869
2021
Q4
$622K Buy
22,416
+21,567
+2,540% +$523K ﹤0.01% 4803
2021
Q3
$18K Buy
849
+298
+54% +$5.59K ﹤0.01% 7268
2021
Q2
$9K Sell
551
-11,903
-96% -$182K ﹤0.01% 8126
2021
Q1
$156K Sell
12,454
-10,096
-45% -$107K ﹤0.01% 5639
2020
Q4
$200K Buy
22,550
+11,453
+103% +$93.2K ﹤0.01% 5240
2020
Q3
$72K Sell
11,097
-5,207
-32% -$33K ﹤0.01% 5393
2020
Q2
$100K Sell
16,304
-7,799
-32% -$47.8K ﹤0.01% 5303
2020
Q1
$162K Sell
24,103
-23,751
-50% -$225K ﹤0.01% 4887
2019
Q4
$557K Buy
47,854
+16,282
+52% +$184K ﹤0.01% 4743
2019
Q3
$325K Buy
31,572
+16,209
+106% +$159K ﹤0.01% 4889
2019
Q2
$144K Buy
15,363
+7,924
+107% +$61K ﹤0.01% 5134
2019
Q1
$52K Sell
7,439
-13,226
-64% -$113K ﹤0.01% 5508
2018
Q4
$152K Buy
20,665
+3,862
+23% +$32.4K ﹤0.01% 5170
2018
Q3
$147K Buy
16,803
+4,833
+40% +$49.4K ﹤0.01% 5275
2018
Q2
$135K Buy
11,970
+2,030
+20% +$24.2K ﹤0.01% 5229
2018
Q1
$111K Buy
9,940
+633
+7% +$7.93K ﹤0.01% 5155
2017
Q4
$118K Buy
9,307
+158
+2% +$2.09K ﹤0.01% 5239
2017
Q3
$130K Buy
9,149
+976
+12% +$12.2K ﹤0.01% 5155
2017
Q2
$106K Buy
8,173
+2,977
+57% +$38.4K ﹤0.01% 5129
2017
Q1
$75K Sell
5,196
-7,995
-61% -$118K ﹤0.01% 5239
2016
Q4
$206K Buy
13,191
+4,489
+52% +$61.5K ﹤0.01% 4765
2016
Q3
$102K Sell
8,702
-9,240
-51% -$122K ﹤0.01% 4980
2016
Q2
$250K Sell
17,942
-26,143
-59% -$346K ﹤0.01% 4398
2016
Q1
$513K Buy
44,085
+7,467
+20% +$94.9K ﹤0.01% 3759
2015
Q4
$600K Buy
36,618
+28,111
+330% +$447K ﹤0.01% 3799
2015
Q3
$116K Buy
8,507
+4,293
+102% +$58.3K ﹤0.01% 5100
2015
Q2
$54K Buy
4,214
+3,739
+787% +$42.4K ﹤0.01% 5941
2015
Q1
$6K Sell
475
-2,927
-86% -$33.5K ﹤0.01% 7993
2014
Q4
$42K Buy
+3,402
New +$34.7K ﹤0.01% 6692

Other funds holding CCRN